父母阿片类处方与子女自杀未遂风险的关联
父母使用阿片类处方与子女自杀未遂风险翻倍相关(OR 1.99,95%CI 1.71-2.33),调整多种混杂因素后关联仍显著,提示应对阿片类使用家庭中的儿童进行心理健康筛查。
要点
- 父母使用阿片类处方与子女自杀未遂风险翻倍相关(OR 1.99)。
- 调整儿童年龄性别、抑郁、物质使用障碍及父母自杀未遂史后关联仍显著。
- 建议对父母使用阿片类的家庭中儿童进行心理健康筛查。
核心结论
- 父母使用处方阿片类与子女自杀未遂风险增加相关,可能是青少年自杀率时间趋势的贡献因素。
研究设计与样本
- 药物流行病学研究,2010年1月1日至2016年12月31日,使用覆盖美国超过1.5亿私人保险人群的MarketScan医疗索赔数据。
- 倾向评分匹配基于人口学特征和伴随精神药物使用识别相关对照家庭。
主要发现
- 未使用阿片类父母的子女中212名(0.14%)发生自杀未遂;使用阿片类父母的子女中678名(0.37%)发生自杀未遂。
- 父母使用阿片类与子代自杀未遂风险翻倍相关(OR 1.99;95%CI 1.71-2.33)。
- 调整儿童年龄和性别后关联显著(OR 1.85;95%CI 1.58-2.17)。
- 进一步调整儿童和父母抑郁及物质使用障碍诊断后关联显著(OR 1.46;95%CI 1.24-1.72)。
- 再调整父母自杀未遂史后关联仍显著(OR 1.45;95%CI 1.23-1.71);地理变异不影响关联(OR 2.00;95%CI 1.71-2.34)。
关键数值与推荐
- 父母阿片类使用定义为2010至2016年间处方覆盖超过365天的阿片类药物。
- 主要结局为子女自杀未遂率。
临床怎么用
- 对父母使用阿片类的家庭,应包含对其子女的心理健康筛查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The rate of youth suicide has increased over the past 15 years in the United States as has the rate of death due to opioid overdose in adults of parental age. OBJECTIVE: To explore the possible connection between parental use of prescription opioids and the increasing rate of youth suicide. DESIGN, SETTING, AND PARTICIPANTS: A pharmacoepidemiologic study was conducted from January 1, 2010, to December 31, 2016, linking medical claims for parental opioid prescriptions with medical claims for suicide attempts by their children. The study used MarketScan medical claims data covering more than 150 million privately insured people in the United States. The study included 121 306 propensity score-matched 30- to 50-year-old parents who used opioids and parents who did not use opioids and their 10- to 19-year-old children (148 395 children of parents who did not use opioids and 184 142 children of parents who used opioids). Propensity score matching was used to identify relevant control families based on demographic features and concomitant use of psychotropic medication. EXPOSURES: Opioid use in a parent was defined as having prescription fills covering more than 365 days of an opioid between 2010 and 2016. MAIN OUTCOMES AND MEASURES: Suicide attempt rate in the children of parents who used opioids and those who did not use opioids. RESULTS: A total of 148 395 children (75 575 sons and 72 820 daughters; mean [SD] age, 11.5 [1.6] years at the start of follow-up) had parents who did not use opioids and 184 142 children (94 502 sons and 89 640 daughters; mean [SD] age, 11.8 [1.8] years at the start of follow-up) with parents who did use opioids. There were 100 899 children aged 10 to 14 years and 47 496 children aged 15 to 19 years with parents who did not use opioids and 96 975 children aged 10 to 14 years and 87 163 children aged 15 to 19 years with parents who did use opioids. Of the children with parents who did not use opioids, 212 (0.14%) attempted suicide; of the children with parents who did use opioids, 678 (0.37%) attempted suicide. Parental use of opioids was associated with a doubling of the risk of a suicide attempt by their offspring (odds ratio [OR], 1.99; 95% CI, 1.71-2.33). The association remained significant after adjusting for child age and sex (OR, 1.85; 95% CI, 1.58-2.17), addition of child and parental depression and diagnoses of substance use disorder (OR, 1.46; 95% CI, 1.24-1.72), and addition of parental history of suicide attempt (OR, 1.45; 95% CI, 1.23-1.71). Geographical variation in opioid use did not change the association (OR, 2.00; 95% CI, 1.71-2.34). CONCLUSIONS AND RELEVANCE: Children of parents who use prescription opioids are at increased risk for suicide attempts, which could be a contributing factor to the time trend in adolescent suicidality. The care of families with a parent who uses opioids should include mental health screening of their children.
引用
- Brent DA, Hur K, Gibbons RD, et al. Association Between Parental Medical Claims for Opioid Prescriptions and Risk of Suicide Attempt by Their Children. JAMA Psychiatry. 2019. PMID: 31116357. doi:10.1001/jamapsychiatry.2019.0940
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。